회사 소개
- 법인명: Pharmaffiliates Pvt. Ltd.
- 등록 국가: India
- 주소: Plot Number 225, Industrial Area, Phase II, Panchkula
- 직원 수: 500 - 999
설명:
Pharmaffiliates is a GLP-compliant CRDO, audited and accepted by the US FDA and accredited to ISO 17034. With more than 24 years of research-driven expertise, the company serves global pharma companies, API manufacturers and CROs, offering reference standards, nitrosamines, peptides and expert solutions in API and formulation development, discovery chemistry and CRDMO, with core services including custom synthesis, analytical R&D, CRAMS (CRO and CDMO), API and formulation development, and HPLC and UPLC columns.
사업 활동
계약 및 아웃소싱 서비스
제조업체서비스 제공업체위탁제조업체 (CMO)시험연구소임상시험수탁기관 (CRO)원자재 공급업체
생산설비 & 유틸리티 시스템
제조업체서비스 제공업체위탁제조업체 (CMO)시험연구소임상시험수탁기관 (CRO)원자재 공급업체
제약용 화학물질
제조업체서비스 제공업체위탁제조업체 (CMO)시험연구소임상시험수탁기관 (CRO)원자재 공급업체
시험분석 서비스
제조업체서비스 제공업체위탁제조업체 (CMO)시험연구소임상시험수탁기관 (CRO)원자재 공급업체
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
주요 제품/서비스
- 계약 및 아웃소싱 서비스: Impurity Synthesis Service, REFERENCE STANDARDS, CAS No : 976-71-6, Canrenone, Aldosterone - In house impurity, (17α)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-carboxylic Acid γ-Lactone
- 생산설비 & 유틸리티 시스템: Formulation & Development
- 임상시험수탁기관 서비스(CRO): CRAMS
- 바이오의약품 서비스: Analytical Services
- 시험분석 서비스: STABILITY STUDIES
당사 제품 & 서비스
Sell · Manufacturing Equipment & Utilities
Offer Service · Laboratory & Analytical Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
Offer Service · Contract & Outsourcing Services
인증
FDA
ISO
증거
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기